Histone Deacetylase Inhibitors Stimulate Cell Migration in Human Endometrial Adenocarcinoma Cells through Up-Regulation of Glycodelin
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Histone deacetylase inhibitors (HDACIs) have recently emerged as promising anticancer drugs to induce cell cycle arrest, cytodifferentiation, and apoptosis. It is suggested, however, that HDACIs promote cell migration and invasion depending on the cell type. We have reported previously that treatment with HDACIs, including trichostatin A and suberoylanilide hydroxamic acid (SAHA) or progesterone in combination with estrogen, can induce cytodifferentiation of endometrial adenocarcinoma Ishikawa cells through up-regulation of glycodelin, a progesterone-induced endometrial glycoprotein. Given the reported role of glycodelin in cell motility and the migration-modulating potential of HDACIs, we investigated using wound healing assay and transwell migration assay whether ovarian steroid hormones, trichostatin A, or SAHA affects cell migration in endometrial cancer cell lines, Ishikawa and RL95-2. Treatment with ovarian steroid hormones, trichostatin A, and SAHA enhanced cell migration together with up-regulation of glycodelin. SAHA-augmented cell migration was almost completely blocked by gene silencing of glycodelin. Furthermore, overexpression of gycodelin alone resulted in increased cell motility in Ishikawa cells. Our results collectively indicate that glycodelin positively regulates cell motility acting as a mediator of HDACI-enhanced endometrial cell migration, suggesting the involvement of glycodelin in the dynamic endometrial gland morphogenesis during menstrual cycle. Our results raise a possibility that the use of HDACIs in the therapy for glycodelin-inducible endometrial and presumably other gynecological cancers may enhance invasion in cases in which the HDACIs fail to exert differentiation-inducing and/or antiproliferative effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Histone acetylases and deacetylases in cell proliferation
Kouzarides, T. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80006-9 · Cited by 601
Seppälä, M., Taylor, R. N., Koistinen, H., Koistinen, R., & Milgrom, E. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0026 · Cited by 262
Histone acetylation and cancer
Archer, S. Y., & Hodint, R. A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80026-4 · Cited by 261
Suppression by human placental protein 14 of natural killer cell activity
OKAMOTO, N., UCHIDA, A., TAKAKURA, K., KARIYA, Y., KANZAKI, H., RIITTINEN, L., KOISTINEN, R., SEPPÄLÄ, M., & MORI, T. (1991) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1991.tb00713.x · Cited by 234 · cited 1×
“It inhibits human sperm-egg binding (23) and has immunosuppressive activity through inactivation of natural killer cells and suppression of T lymphocyte proliferation (24, 25), presumably functioning to avoid multiple pregnancy and to protect the embryonic semiallograft from maternal immune attack.”
BackgroundHistone Deacetylase Inhibitors Have a Profound Antigrowth Activity in Endometrial Cancer Cells
Takai, N., Desmond, J. C., Kumagai, T., Gui, D., Said, J. W., Whittaker, S., Miyakawa, I., & Koeffler, H. P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0100 · Cited by 233
Valproic Acid Inhibits Angiogenesis in Vitro and in Vivo
Michaelis, M., Michaelis, U. R., Fleming, I., Suhan, T., Cinatl, J., Blaheta, R. A., Hoffmann, K., Kotchetkov, R., Busse, R., Nau, H., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.520 · Cited by 227
Liu, L., Chang, H., Chiang, L., & Hung, W. (2003) · PubMed · Cited by 227
The Ishikawa Cells from Birth to the Present
Nishida, M. (2002) · Human Cell · doi:10.1111/j.1749-0774.2002.tb00105.x · Cited by 210
Oehninger, S., Coddington, C. C., Hodgen, G. D., & Seppala, M. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57372-5 · Cited by 188
Cited by
Transition from inflammation to proliferation: a critical step during wound healing
Landén, N. X., Li, D., & Ståhle, M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2268-0 · Cited by 1,980
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Role of nuclear progesterone receptor isoforms in uterine pathophysiology
Patel, B., Elguero, S., Thakore, S., Dahoud, W., Bedaiwy, M., & Mesiano, S. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu056 · Cited by 353
Role of Progesterone in Endometrial Cancer
Kim, J., & Chapman-Davis, E. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0029-1242998 · Cited by 213
Molecular and Cellular Mechanisms for Differentiation and Regeneration of the Uterine Endometrium
MARUYAMA, T., & YOSHIMURA, Y. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-067 · Cited by 174
Self-citationClass I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
Fritzsche, F. R., Weichert, W., Röske, A., Gekeler, V., Beckers, T., Stephan, C., Jung, K., Scholman, K., Denkert, C., Dietel, M., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-381 · Cited by 163
Uchida, H., Maruyama, T., Nishikawa-Uchida, S., Oda, H., Miyazaki, K., Yamasaki, A., & Yoshimura, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.286138 · Cited by 86
Self-citationArase, T., Uchida, H., Kajitani, T., Ono, M., Tamaki, K., Oda, H., Nishikawa, S., 各務, 真., Nagashima, T., Masuda, H., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900001 · Cited by 83
Self-citationLin, K.-T., Wang, Y.-W., Chen, C.-T., Ho, C.-M., Su, W.-H., & Jou, Y.-S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0633 · Cited by 80
EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis
Ihira, K., Dong, P., Xiong, Y., Watari, H., Konno, Y., Hanley, S. J. B., Noguchi, M., Hirata, N., Suizu, F., Yamada, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14586 · Cited by 79
The differential short- and long-term effects of HIV-1 latency-reversing agents on T cell function
Clutton, G., Xu, Y., Baldoni, P. L., Mollan, K. R., Kirchherr, J., Newhard, W., Cox, K., Kuruc, J. D., Kashuba, A. D. M., Barnard, R., et al. (2016) · Scientific Reports · doi:10.1038/srep30749 · Cited by 78
Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation
Uchida, H., Maruyama, T., Ohta, K., Ono, M., Arase, T., 各務, 真., Oda, H., Kajitani, T., Asada, H., & Yoshimura, Y. (2007) · Human Reproduction · doi:10.1093/humrep/dem263 · Cited by 65
Self-citationThe Epigenetic Regulation of Wound Healing
Lewis, C. J., Mardaryev, A. N., Sharov, A. A., Fessing, M. Y., & Botchkarev, V. A. (2014) · Advances in Wound Care · doi:10.1089/wound.2014.0522 · Cited by 66
Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy
Pattabiraman, D. R., & Weinberg, R. A. (2016) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2016.81.030957 · Cited by 62
Lipocalin-2-induced cytokine production enhances endometrial carcinoma cell survival and migration
Lin, H.-H., Liao, C.-J., Lee, Y.-C., Hu, K.-H., Meng, H.-W., & Chu, S.-T. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.74 · Cited by 60
Pulukuri, S. M. K., Gorantla, B., & Rao, J. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705867200 · Cited by 51
RetractedOrganoids to model the endometrium: implantation and beyond
Rawlings, T. M., Makwana, K., Tryfonos, M., & Lucas, E. S. (2021) · Reproduction and Fertility · doi:10.1530/raf-21-0023 · Cited by 50
Uchida, H., Maruyama, T., Nishikawa-Uchida, S., Miyazaki, K., Masuda, H., & Yoshimura, Y. (2013) · Reproductive Medicine and Biology · doi:10.1007/s12522-013-0144-2 · Cited by 48
Self-citationYan, Z., Yao, Q.-P., Zhang, M.-L., Qi, Y.-X., Guo, Z., Shen, B., & Jiang, Z. (2009) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2009.01.012 · Cited by 43
Elevated Immunoreactivity against Class I Histone Deacetylases in Adenomyosis
Liu, X., Nie, J., & Guo, S.-W. (2012) · Gynecologic and Obstetric Investigation · doi:10.1159/000336409 · Cited by 41
The Roles of Glycodelin in Cancer Development and Progression
Cui, J., Liu, Y., & Wang, X. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01685 · Cited by 36
Duncan, H. F., Smith, A. J., Fleming, G. J. P., Partridge, N. C., Shimizu, E., Moran, G. P., & Cooper, P. R. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25128 · Cited by 41
An, Z., Gluck, C. B., Choy, M. L., & Kaufman, L. J. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.12.006 · Cited by 37
Mitmaker, E. J., Griff, N. J., Grogan, R. H., Sarkar, R., Kebebew, E., Duh, Q., Clark, O. H., & Shen, W. T. (2010) · Surgery · doi:10.1016/j.surg.2010.10.007 · Cited by 33
The Metabolite GnRH-(1-5) Inhibits the Migration of Immortalized GnRH Neurons
Larco, D. O., Cho-Clark, M. J., Mani, S. K., & Wu, T. J. (2013) · Endocrinology · doi:10.1210/en.2012-1746 · Cited by 32
Singh, B. N., Zhou, H., Li, J., Tipton, T., Wang, B., Shao, G., Gilbert, E. N., Li, Q., & Jiang, S. (2011) · Future Oncology · doi:10.2217/fon.11.124 · Cited by 30
Functional characterization of the progestagen‐associated endometrial protein gene in human melanoma
Ren, S., Liu, S., Howell, P., Zhang, G., Pannell, L. K., Samant, R. S., Shevde‐Samant, L., Tucker, J. A., Fodstad, Ø., & Riker, A. I. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00922.x · Cited by 28
β-Arrestin 2 Is a Mediator of GnRH-(1–5) Signaling in Immortalized GnRH Neurons
Larco, D. O., Semsarzadeh, N. N., Cho-Clark, M. J., Mani, S. K., & Wu, T. J. (2013) · Endocrinology · doi:10.1210/en.2013-1286 · Cited by 28
HDAC as a Therapeutic Target for Treatment of Endometrial Cancers
Ren, J., Zhang, J., Cai, H., Li, Y., Zhang, Y., Zhang, X., Zhao, D., Li, Z., Ma, H., Wang, J., et al. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990528 · Cited by 28
Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
Lenhard, M., Heublein, S., Kunert‐Keil, C., Vrekoussis, T., Lomba, I., Ditsch, N. C., Mayr, D. C., Friese, K., & Jeschke, U. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-616 · Cited by 28
Mendivil, A. A., Micha, J. P., Brown, J. V., Rettenmaier, M. A., Abaid, L. N., Lopez, K. L., & Goldstein, B. H. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31828566f1 · Cited by 27
Yamamoto, A., Ashihara, E., Nakagawa, Y., Obayashi, H., Ohta, M., Hara, H., Adachi, T., Seno, T., Kadoya, M., Hamaguchi, M., et al. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.10.015 · Cited by 26
The endometrial epigenome and its response to steroid hormones
Guo, S. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.025 · Cited by 26
Ohta, K., Maruyama, T., Uchida, H., Ono, M., Nagashima, T., Arase, T., Kajitani, T., Oda, H., Morita, M., & Yoshimura, Y. (2008) · Molecular Human Reproduction · doi:10.1093/molehr/gam081 · Cited by 24
Self-citationImmunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer
Jeschke, U., Mylonas, I. G., Kunert‐Keil, C., Stahn, R., Scholz, C., Janni, W., Kühn, C., Schröder, E., Mayr, D. C., & Friese, K. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0510-z · Cited by 21
Chapter 2 Progesterone Receptor Action in Leiomyoma and Endometrial Cancer
Kim, J. J., Sefton, E. C., & Bulun, S. E. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)87002-6 · Cited by 28
Tissue-engineered multi-cellular models of the uterine wall
Kuperman, T., Gavriel, M., Gotlib, R., Zhang, Y., Jaffa, A. J., Elad, D., & Grisaru, D. (2020) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-020-01296-6 · Cited by 18
Bergadà, L., Sorolla, A., Yeramian, A., Eritja, N., Mirantes, C., Matías‐Guiu, X., & Dolcet, X. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.03.003 · Cited by 19
Ren, S., Chai, L., Wang, C., Li, C., Ren, Q., Yang, L., Wang, F., Qiao, Z., Li, W., He, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119038 · Cited by 18
The role of glycodelin in cell differentiation and tumor growth
Koistinen, H. K., Hautala, L. C., Seppälä, M. T., Stenman, U., Laakkonen, P. M., & Koistinen, R. (2009) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510903056023 · Cited by 16
Chen, J.-S., Chang, L.-C., Wu, C., Yeung, L.-K., & Lin, Y. (2011) · Experimental Diabetes Research · doi:10.1155/2011/565647 · Cited by 15
Tzao, C., Jin, J.-S., Chen, B.-H., Chung, H.-Y., Chang, C., Hsu, T.-F., & SUN, G.-H. (2013) · Diseases of the Esophagus · doi:10.1111/dote.12127 · Cited by 12
How to Create an Embryo Penetration Route
Uchida, H., Maruyama, T., Masuda, H., Uchida, S., Miki, F., Hihara, H., Katakura, S., Yoshimasa, Y., & Tanaka, M. (2016) · American Journal of Reproductive Immunology · doi:10.1111/aji.12476 · Cited by 12
Self-citationXiong, G., Zhang, Y.-S., Han, B., Chen, W., Yang, Y., & Peng, J. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.06.003 · Cited by 12
Banik, A., Ahmed, S. R., Sajib, E. H., Deb, A., Sinha, S., & Azim, K. F. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10345-w · Cited by 11
Histone deacetylase inhibitors as therapeutics for endometriosis
Li, X., Liu, X., & Guo, S. (2012) · Expert Review of Obstetrics & Gynecology · doi:10.1586/eog.12.52 · Cited by 11
Epithelial mesenchymal transition in human menstruation and implantation
Uchida, H. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej24-0229 · Cited by 11
Self-citationFernandes, C. B., Loux, S. C., Scoggin, K. E. S., Squires, E. L., Troedsson, M. H. T., Esteller‐Vico, A., & Ball, B. A. (2017) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2017.10.018 · Cited by 9
Ren, S., Howell, P., Han, Y., Wang, J., Liu, M., Wang, Y., Quan, G., Du, W., Fang, L., & Riker, A. I. (2011) · PubMed Central · Cited by 10
Shchelkunova, T. A., & Morozov, I. A. (2016) · Molecular Biology · doi:10.1134/s0026893316010179 · Cited by 7
HDACI regulates the PI3K/Akt signaling pathway to reverse MCF-7/PTX resistance by inhibiting SET
Zhang, W., Zheng, X., Meng, T., You, H., Dong, Y., Xing, J., & Chen, S. (2016) · RSC Advances · doi:10.1039/c6ra06423j · Cited by 3
CHAI, L., Qiao, Z., WANG, J., Liu, M., Wang, Y., Wang, X., He, M., Li, W., Yu, Q., Han, Y., et al. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1679 · Cited by 2
Kar, K., Chakraborty, P., Chowdhury, S., Singh, K. P., Singh, M. P., & Singh, S. K. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102400 · Cited by 2
Epigenetic Treatment in Assisted Human Embryo Implantation
Uchida, H., Maruyama, T., 各務, 真., Oda, H., Nishikawa, S., Kajitani, T., Asada, H., & Yoshimura, Y. (2009) · Journal of Mammalian Ova Research · doi:10.1274/jmor.26.116 · Cited by 1
Self-citationHautala, L. C., Koistinen, R., & Koistinen, H. K. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.06.020 · Cited by 2
Guo, S. (2011) · Wiley eBooks · doi:10.1002/9781444398519.ch7 · Cited by 1
Three-dimensional modelling of the human peri-implantation endometrium
Rawlings, T. M. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33812119
Metadata
- Authors
- Uchida, H., Maruyama, T., Ono, M., Ohta, K., Kajitani, T., Masuda, H., Nagashima, T., Arase, T., Asada, H., & Yoshimura, Y.
- Affiliations
- Keio University (JP)
- Corresponding author
- Maruyama, Tetsuo
- ORCID
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-02-01
- Volume
- 148
- Issue
- 2
- Pages
- 896-902
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W1990612902
- Cited by
- 59
- References
- 31
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2021: 2 · 2020: 1 · 2017: 3 · 2016: 7 · 2015: 4 · 2014: 3 · 2013: 9 · 2012: 3
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Keywords
- histone deacetylase inhibitors, glycodelin, endometrial adenocarcinoma, cell migration, trichostatin A, vorinostat, ovarian steroids, progesterone, estrogen, Ishikawa cells, RL95-2 cells, tumor invasion, cell motility
- MeSH terms
- Glycodelin, Vorinostat, Adenocarcinoma, Antineoplastic Agents, Cell Movement, Enzyme Inhibitors, Female, Fibronectins, Glycoproteins, Humans, Hydroxamic Acids, Ovary, Pregnancy Proteins, Up-Regulation, Endometrial Neoplasms, Cell Line, Tumor, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.